https://www.switzerlandhealthmonitor.com/article/911295718-last-day-of-flower-turbines-small-wind-energy-sale Switzerland Health Monitor en PressRelease 2026-05-08T05:53:11+00:00 Last Day of Flower Turbines small wind energy sale https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850913-last-day-of-eu-sale-1080x1350.png https://www.switzerlandhealthmonitor.com/article/910824767-sgs-awards-dobot-robotics-iso-10218-cybersecurity-certification Switzerland Health Monitor en PressRelease 2026-05-07T08:39:48+00:00 SGS awards DOBOT robotics ISO 10218 cybersecurity certification https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24849117-dobot-series-undergoing-testing-1916x1279.jpeg https://www.switzerlandhealthmonitor.com/article/911087163-novartis-breaks-ground-on-denton-texas-radioligand-therapy-site-construction-now-underway-across-all-new-us-facilities Switzerland Health Monitor en PressRelease 2026-05-07T13:00:00+00:00 Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg https://www.switzerlandhealthmonitor.com/article/911051172-oculis-announces-agreement-with-fda-on-a-special-protocol-assessment-spa-for-optic-neuritis-registrational-trial Switzerland Health Monitor en PressRelease 2026-05-07T08:57:22+00:00 Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.switzerlandhealthmonitor.com/article/911006734-kuros-biosciences-appoints-i-v-hall-as-chief-operating-officer-deepening-operational-r-d-and-extremities-leadership-for-next-phase-of-growth Switzerland Health Monitor en PressRelease 2026-05-07T05:00:00+00:00 Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth https://ml-eu.globenewswire.com/media/ad3777c9-af1f-4b09-a899-3b3d6b8e962d/small/kuros-logo-jpg.jpg